Added to YB: 2026-03-06
Pitch date: 2026-03-04
HIMS [neutral]
Hims & Hers Health, Inc.
Author Info
Company Info
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally.
Market Cap
$3.6B
Pitch Price
N/A
Price Target
N/A
Dividend
N/A
EV/EBITDA
21.93
P/E
30.88
EV/Sales
1.77
Sector
Health Care Providers and Services
Category
growth
A Primer on Hims & Hers
HIMS (overview): D2C telehealth platform w/ subscription model for sexual health, hair loss, hormones, weight loss, dermatology, mental health. WM segment hit by end of GLP-1 shortage, FDA tightening, price cuts, Novo lawsuit. Growth slowed H2/25; Q4 faced $65M rev headwind from shipping protocol changes. Revival via Labs (70% convert to treatment), HERS ($1B+ rev FY26 est, HRT focus), testosterone, longevity. $1.15B Eucalyptus acquisition for intl expansion (AU/UK/DE/JP). Risks: regulatory challenges, competition, WM headwinds.
Read full article (6 min)